Immatics (IMTX) Invested Capital (2019 - 2025)
Immatics recorded quarterly Invested Capital of $1.5 billion in Q4 2025, up 205.24% quarter-over-quarter from $487.1 million in Q3 2025, and up 142.05% year-over-year from $614.3 million in Q4 2024.
Immatics' Invested Capital history runs 7 years deep, the most recent figure standing at $1.5 billion for Q4 2025.
- In Q4 2025, Invested Capital rose 142.05% year-over-year to $1.5 billion; the TTM figure through Dec 2025 stood at $1.5 billion (up 142.05% YoY), while the FY2025 annual figure was $1.4 billion, up 134.94% from the prior year.
- Invested Capital came in at $1.5 billion for Q4 2025 at Immatics, up from $487.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.5 billion in Q4 2025 to a low of $72.4 million in Q3 2021.
- A 5-year average of $343.7 million and a median of $235.9 million in 2023 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital slumped 89.12% in 2021 and surged 182.17% in 2022, its largest moves.
- Immatics' Invested Capital stood at $73.5 million in 2021, then soared by 182.17% to $207.5 million in 2022, then climbed by 12.86% to $234.1 million in 2023, then surged by 162.35% to $614.3 million in 2024, then soared by 142.05% to $1.5 billion in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $1.5 billion, $487.1 million, and $525.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 1.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 487.12 Mn |
| Jun 30, 2025 | 525.88 Mn |
| Mar 31, 2025 | 564.45 Mn |
| Dec 31, 2024 | 614.27 Mn |
| Sep 30, 2024 | 416.41 Mn |
| Jun 30, 2024 | 410.58 Mn |
| Mar 31, 2024 | 428.17 Mn |
| Dec 31, 2023 | 234.14 Mn |
| Sep 30, 2023 | 269.70 Mn |
| Jun 30, 2023 | 237.62 Mn |
| Mar 31, 2023 | 214.76 Mn |
| Dec 31, 2022 | 207.47 Mn |
| Sep 30, 2022 | 134.13 Mn |
| Jun 30, 2022 | 148.38 Mn |
| Mar 31, 2022 | 142.89 Mn |
| Dec 31, 2021 | 73.53 Mn |
| Sep 30, 2021 | 72.43 Mn |
| Jun 30, 2021 | 92.05 Mn |
| Mar 31, 2021 | 113.01 Mn |
| Dec 31, 2020 | 675.53 Mn |
| Jun 30, 2020 | -289.18 Mn |
| Dec 31, 2019 | -248.85 Mn |
| Jun 30, 2019 | -240.20 Mn |